Literature DB >> 24424947

Axotomy-induced target disconnection promotes an additional death mechanism involved in motoneuron degeneration in amyotrophic lateral sclerosis transgenic mice.

Melissa M Haulcomb1, Nichole A Mesnard, Richard J Batka, Thomas D Alexander, Virginia M Sanders, Kathryn J Jones.   

Abstract

The target disconnection theory of amyotrophic lateral sclerosis (ALS) pathogenesis suggests that disease onset is initiated by a peripheral pathological event resulting in neuromuscular junction loss and motoneuron (MN) degeneration. Presymptomatic mSOD1(G93A) mouse facial MN (FMN) are more susceptible to axotomy-induced cell death than wild-type (WT) FMN, which suggests additional CNS pathology. We have previously determined that the mSOD1 molecular response to facial nerve axotomy is phenotypically regenerative and indistinguishable from WT, whereas the surrounding microenvironment shows significant dysregulation in the mSOD1 facial nucleus. To elucidate the mechanisms underlying the enhanced mSOD1 FMN loss after axotomy, we superimposed the facial nerve axotomy model on presymptomatic mSOD1 mice and investigated gene expression for death receptor pathways after target disconnection by axotomy vs. disease progression. We determined that the TNFR1 death receptor pathway is involved in axotomy-induced FMN death in WT and is partially responsible for the mSOD1 FMN death. In contrast, an inherent mSOD1 CNS pathology resulted in a suppressed glial reaction and an upregulation in the Fas death pathway after target disconnection. We propose that the dysregulated mSOD1 glia fail to provide support the injured MN, leading to Fas-induced FMN death. Finally, we demonstrate that, during disease progression, the mSOD1 facial nucleus displays target disconnection-induced gene expression changes that mirror those induced by axotomy. This validates the use of axotomy as an investigative tool in understanding the role of peripheral target disconnection in the pathogenesis of ALS.
Copyright © 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  ALS; MN; SOD1; facial nerve axotomy; gene expression; motoneuron

Mesh:

Substances:

Year:  2014        PMID: 24424947      PMCID: PMC4046277          DOI: 10.1002/cne.23538

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  103 in total

1.  Caspase-3 is activated following axotomy of neonatal facial motoneurons and caspase-3 gene deletion delays axotomy-induced cell death in rodents.

Authors:  J L Vanderluit; L T McPhail; K J Fernandes; C B McBride; C Huguenot; S Roy; G S Robertson; D W Nicholson; W Tetzlaff
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

2.  Transcriptional and post-transcriptional mechanisms regulating neurofilament and tubulin gene expression during normal development of the rat brain.

Authors:  P F Moskowitz; M M Oblinger
Journal:  Brain Res Mol Brain Res       Date:  1995-06

3.  Androgenic regulation of tubulin gene expression in axotomized hamster facial motoneurons.

Authors:  K J Jones; M M Oblinger
Journal:  J Neurosci       Date:  1994-06       Impact factor: 6.167

4.  GAP-43 immunoreactivity is detected in the nerve terminals of patients with amyotrophic lateral sclerosis.

Authors:  A Ueki; Y Namba; M Otsuka; M Okuno; M Nishimura; M Oda; K Ikeda
Journal:  Ann Neurol       Date:  1993-02       Impact factor: 10.422

Review 5.  Molecular basis of amyotrophic lateral sclerosis.

Authors:  Rajka M Liscic; Davorka Breljak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-07-23       Impact factor: 5.067

6.  Neuron-specific expression of mutant superoxide dismutase 1 in transgenic mice does not lead to motor impairment.

Authors:  A Pramatarova; J Laganière; J Roussel; K Brisebois; G A Rouleau
Journal:  J Neurosci       Date:  2001-05-15       Impact factor: 6.167

7.  New expression of myelomonocytic antigens by microglia and perivascular cells following lethal motor neuron injury.

Authors:  M B Graeber; W J Streit; R Kiefer; S W Schoen; G W Kreutzberg
Journal:  J Neuroimmunol       Date:  1990-05       Impact factor: 3.478

Review 8.  TNF-alpha inhibition as a treatment strategy for neurodegenerative disorders: new drug candidates and targets.

Authors:  David Tweedie; Kumar Sambamurti; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2007-09       Impact factor: 3.498

9.  Primary structure of GAP-43 mRNA expressed in the spinal cord of ALS patients.

Authors:  M Kage; A Ikemoto; I Akiguchi; J Kimura; S Matsumoto; H Kimura; I Tooyama
Journal:  Neuroreport       Date:  1998-05-11       Impact factor: 1.837

10.  IL-10 within the CNS is necessary for CD4+ T cells to mediate neuroprotection.

Authors:  Junping Xin; Derek A Wainwright; Nichole A Mesnard; Craig J Serpe; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2010-08-17       Impact factor: 7.217

View more
  9 in total

1.  Facial nerve axotomy in mice: a model to study motoneuron response to injury.

Authors:  Deborah N Olmstead; Nichole A Mesnard-Hoaglin; Richard J Batka; Melissa M Haulcomb; Whitney M Miller; Kathryn J Jones
Journal:  J Vis Exp       Date:  2015-02-23       Impact factor: 1.355

2.  Impact of peripheral immune status on central molecular responses to facial nerve axotomy.

Authors:  D O Setter; E M Runge; N D Schartz; F M Kennedy; B L Brown; K P McMillan; W M Miller; K M Shah; M M Haulcomb; V M Sanders; K J Jones
Journal:  Brain Behav Immun       Date:  2017-10-10       Impact factor: 7.217

Review 3.  CD4 + T Cells and Neuroprotection: Relevance to Motoneuron Injury and Disease.

Authors:  Kathryn J Jones; Amy E Lovett-Racke; Chandler L Walker; Virginia M Sanders
Journal:  J Neuroimmune Pharmacol       Date:  2015-07-07       Impact factor: 4.147

4.  Identification of B6SJL mSOD1(G93A) mouse subgroups with different disease progression rates.

Authors:  Melissa M Haulcomb; Nichole A Mesnard-Hoaglin; Richard J Batka; Rena M Meadows; Whitney M Miller; Kathryn P Mcmillan; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  J Comp Neurol       Date:  2015-06-22       Impact factor: 3.215

5.  SOD1(G93A) transgenic mouse CD4(+) T cells mediate neuroprotection after facial nerve axotomy when removed from a suppressive peripheral microenvironment.

Authors:  Nichole A Mesnard-Hoaglin; Junping Xin; Melissa M Haulcomb; Richard J Batka; Virginia M Sanders; Kathryn J Jones
Journal:  Brain Behav Immun       Date:  2014-06-06       Impact factor: 7.217

6.  Identification of a resilient mouse facial motoneuron population following target disconnection by injury or disease.

Authors:  Deborah O Setter; Melissa M Haulcomb; Taylor Beahrs; Rena M Meadows; Nicole D Schartz; Sara K Custer; Virginia M Sanders; Kathryn J Jones
Journal:  Restor Neurol Neurosci       Date:  2018       Impact factor: 2.406

7.  Locomotor analysis identifies early compensatory changes during disease progression and subgroup classification in a mouse model of amyotrophic lateral sclerosis.

Authors:  Melissa M Haulcomb; Rena M Meadows; Whitney M Miller; Kathryn P McMillan; MeKenzie J Hilsmeyer; Xuefu Wang; Wesley T Beaulieu; Stephanie L Dickinson; Todd J Brown; Virginia M Sanders; Kathryn J Jones
Journal:  Neural Regen Res       Date:  2017-10       Impact factor: 5.135

8.  CD4+ T cell expression of the IL-10 receptor is necessary for facial motoneuron survival after axotomy.

Authors:  Elizabeth M Runge; Abhirami K Iyer; Deborah O Setter; Felicia M Kennedy; Virginia M Sanders; Kathryn J Jones
Journal:  J Neuroinflammation       Date:  2020-04-17       Impact factor: 8.322

9.  Modeling Environmentally-Induced Motor Neuron Degeneration in Zebrafish.

Authors:  Jessica R Morrice; Cheryl Y Gregory-Evans; Christopher A Shaw
Journal:  Sci Rep       Date:  2018-03-20       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.